Indirect enhancement of neutrophil activity and adhesion to cultured human umbilical vein endothelial cells by isoprostanes (iPF2α-III and iPE2-III)

This publication has 24 references indexed in Scilit:

• Prostaglandin F₂-Like Compounds, F₂-Isoprostanes, Are Present in Increased Amounts in Human Atherosclerotic Lesions
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Hemodynamic Effects of Isoprostanes (8-Iso-Prostaglandin F2α and E2) in Isolated Guinea Pig Hearts
  Journal of Cardiovascular Pharmacology, 1997
• Stimulatory Effect of 8-Epi-PGF2α, An F2-Isoprostane, on Endothelin-1 Release
  Journal of Cardiovascular Pharmacology, 1995
• Formation of F₂‐isoprostanes during aortic endothelial cell‐mediated oxidation of low density lipoprotein
  FEBS Letters, 1994
• Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.
  Journal of Clinical Investigation, 1992
• ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).
  The Journal of cell biology, 1990
• Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevance
  Journal of the American College of Cardiology, 1990
• The role of the neutrophil and free radicals in ischemic myocardial injury
  Journal of Molecular and Cellular Cardiology, 1989
• Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
  Journal of Clinical Investigation, 1989
• Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family.
  Journal of Clinical Investigation, 1989